Top Markets
#1 Decred Decred +8.72%
#2 Wibx Wibx +8.37%
#3 Status Status +7.35%
#4 SkyAI SkyAI +5.40%
#5 aelf aelf +5.26%
#6 MarsCoin MarsCoin +5.08%
#7 TRIA TRIA +4.98%
#8 Rei Rei +4.63%
#9 Wrapped Flare Wrapped Flare +4.46%
#10 DexNet DexNet +3.98%
Coin of the day
Decred Decred
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc

FRLN
Classifica tra le azioni #30823
Freeline Therapeutics Holdings plc is a biopharmaceutical company, currently in... Freeline Therapeutics Holdings plc is a biopharmaceutical company, currently in its clinical development phase, focused on creating groundbreaking gene therapies. These innovative treatments leverage adeno-associated virus (AAV) vector technology to tackle inherited, systemic, and severely debilitating genetic conditions. The company's leading therapeutic candidate, verbrinacogene setparvovec (FLT180a), is presently undergoing Phase 1/2 clinical trials for the management of hemophilia B in adult males. Furthermore, Freeline's pipeline features FLT190, which is also in Phase 1/2 clinical evaluation for treating Fabry disease, and FLT201, a gene therapy designed to target the liver for type 1 Gaucher disease, likewise progressing through Phase 1/2 trials. Beyond these specific programs, the company is actively pursuing research initiatives across a range of other systemic gene therapy indications. Freeline was established in 2015 and operates from its headquarters in Stevenage, United Kingdom.
Prezzo delle azioni
$6.48
Ultima sincronizzazione: 2024-02-29
Capitalizzazione di mercato
$15.41M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Freeline Therapeutics Holdings plc (FRLN)

Categoria

Healthcare
Storico del prezzo dell'azione per Freeline Therapeutics Holdings plc (FRLN)
Prezzo di chiusura più alto: $6.46 il 2024-02-01

Prezzo di chiusura più basso: $253.54 il 2020-08-01
Storico del prezzo dell'azione di Freeline Therapeutics Holdings plc dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 1.37%
2023 -20.74%
2022 -75.54%
2021 -87.40%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.42 -20.02%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE